Japanese Journal of Clinical Oncology Advance Access published online on February 3, 2009
Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hyn158
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author (2009). Published by Oxford University Press. All rights reserved
Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
For reprints and all correspondence: Yong Chan Ahn, Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. E-mail: ahnyc{at}skku.edu, ycahn.ahn{at}samsung.com; Hee Chul Park, Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. E-mail: rophc{at}skku.edu, hee.ro.park{at}samsung.com
Received October 5, 2008; accepted December 18, 2008
Objective: This study was undertaken to identify the factors predictive of radiation pneumonitis (RP) in 69 non-small cell lung cancer patients treated with thoracic radiation therapy only by 3 Gy fractions.
Methods: A total of 69 patients who received only RT in daily 3 Gy were included in this study. Grade
3 RP was defined as an RP event. The cumulative incidence of RP was estimated and the correlations of the development of RP with the potential predictors were determined.
Results: The cumulative incidence of events was 17.1% at 12 months. By univariate analysis, all clinical factors [age, performance status, weight loss, pre-RT forced expiratory volume in 1 s, tumour location, stage, RT dose and clinical target volume] were not associated with the risk of Grade
3 RP; however, all dosimetric factors [V5–50 and mean lung dose (MLD)] closely correlated with the development of RP. The receiver-operative characteristics (ROC) analysis revealed that MLD was the best predictors of Grade
3 RP (area under curve ROC = 0.937). By multivariate analysis, MLD was the only significant factor to be predictive of RP risk: the probability of Grade
3 RP was 3.7% when MLD
16.1 Gy and 78.4% when MLD > 16.1 Gy.
Conclusions: Dosimetric parameters were valuable in predicting the development of RP.
Key Words: radiation pneumonitis radiation therapy hypofractionated treatment lung cancer